BUY Artemis Medicare Services Limited — Kush Bohra
byKush BohraHorizon: NA (inferred Intraday)5 Aug 2026, 1:42 pm ISTvia NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Artemis Medicare Services Limited reported a 12.7% YoY increase in consolidated revenue for Q1 FY27, with EBITDA up 27.9% and profit up 48.3%.
NSE · Press Release·3 Aug · yesterday
Artemis Medicare Services Ltd announced its Q1 FY27 financial results, showing a 12.7% YoY increase in consolidated revenue to Rs 28,732 Lacs. EBITDA grew by 27.9% to Rs 6,182 Lacs, and PAT increased
BSE · Company Update·3 Aug · yesterday
Artemis Medicare Services Limited announced its un-audited financial results for the quarter ended June 30, 2026, and an expansion plan for Tower IV at its flagship hospital in Gurugram.
NSE · Outcome of Board Meeting·3 Aug · yesterday
Artemis Medicare Services Ltd announced the outcome of its Board Meeting held on August 3, 2026. The board approved the un-audited financial results for the quarter ended June 30, 2026, and an expansi
BSE · Board Meeting·3 Aug · yesterday
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.